| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.72 | $43.01 (0%) | 🛒 Add to cart |
| 90 | $0.67 | $64.52 $60.02 (7%) | 🛒 Add to cart |
| 120 | $0.63 | $86.03 $76.02 (12%) | 🛒 Add to cart |
| 180 | $0.61 | $129.04 $109.04 (16%) | 🛒 Add to cart |
| 270 | $0.59 | $193.56 $159.05 (18%) | 🛒 Add to cart |
| 360 | $0.58
Best per pill | $258.08 $209.07 (19%) | 🛒 Add to cart |
Synonyms
| |||
Similar products
More info:
tamoxifen
Tamoxifen citrate represents one of those rare molecules that fundamentally changed how we approach hormone-sensitive cancers. When I first started in oncology back in the late 90s, we were still figuring out the optimal sequencing for this selective estrogen receptor modulator (SERM). It’s fascinating how a drug originally investigated as a contraceptive became the cornerstone of breast cancer management for decades. The standard 20mg tablet contains tamoxifen citrate equivalent to tamoxifen base, with standard pharmaceutical excipients.
androxal
Androxal represents one of the more interesting developments in male endocrinology we’ve seen in recent years—it’s not your typical testosterone booster, but rather a selective estrogen receptor modulator (SERM) with a very specific mechanism. I first encountered it during a particularly stubborn case of iatrogenic hypogonadism in a bodybuilder who’d crashed his HPTA with prohormones. Nothing was working to restart his axis—not clomiphene, not HCG monotherapy. That’s when our clinic started looking at enclomiphene citrate, the purified isomer that makes up Androxal.
Arimidex: Estrogen Suppression for Breast Cancer Treatment - Evidence-Based Review
Anastrozole, marketed under the brand name Arimidex, represents a cornerstone in the endocrine therapy arsenal for hormone receptor-positive breast cancer. This non-steroidal aromatase inhibitor fundamentally alters the hormonal landscape in postmenopausal women by selectively blocking the conversion of androgens to estrogens in peripheral tissues. Unlike earlier generations of hormonal therapies that carried more significant side effect profiles, Arimidex offers a targeted approach to estrogen suppression that has demonstrated superior efficacy in multiple large-scale clinical trials.
Aromasin: Estrogen Suppression for Hormone-Sensitive Breast Cancer - Evidence-Based Review
Aromasin, known generically as exemestane, is an oral steroidal aromatase inactivator used primarily in postmenopausal women with hormone receptor-positive early and advanced breast cancer. It functions by irreversibly binding to the aromatase enzyme, which is responsible for converting androgens into estrogens in peripheral tissues. This results in a significant reduction of circulating estrogen levels, which can starve estrogen-dependent tumor cells. The product is available as 25 mg film-coated tablets and is typically administered once daily after a meal to enhance absorption.
asendin
Let me walk you through what we’ve learned about Asendin over the past decade. When it first hit our formulary back in 2014, we were all pretty skeptical - another “natural” antidepressant claiming to rival pharmaceuticals without the side effects. The initial product description positioned it as a standardized Hypericum perforatum extract with additional GABAergic compounds, but the real story emerged through clinical use. Asendin: Evidence-Based Support for Treatment-Resistant Depression 1.
bupropion
Bupropion is an atypical antidepressant belonging to the norepinephrine-dopamine reuptake inhibitor (NDRI) class, chemically distinct from SSRIs and SNRIs. Initially approved for depression in 1985, it has since gained indications for smoking cessation and seasonal affective disorder. Its unique mechanism—avoiding serotonin pathways—makes it particularly valuable for patients who can’t tolerate sexual side effects or weight gain associated with other antidepressants. We’ve been using it in our practice since the late 90s, and I still remember our initial skepticism about an antidepressant that didn’t touch serotonin.
casodex
Casodex, known generically as bicalutamide, is a non-steroidal anti-androgen medication primarily used in the management of prostate cancer. It functions by competitively inhibiting androgen binding to androgen receptors in target tissues, thereby blocking the stimulatory effects of androgens on prostate cancer growth. Casodex is typically administered orally in tablet form and is often used in combination with a luteinizing hormone-releasing hormone (LHRH) analog as part of combined androgen blockade therapy for advanced prostate cancer.
clomid
Clomiphene citrate, commonly known by its brand name Clomid, represents one of the most foundational and extensively studied oral ovulation induction agents in reproductive medicine. As a selective estrogen receptor modulator (SERM), its primary mechanism involves blocking estrogen receptors at the hypothalamic level, which tricks the body into perceiving low estrogen levels. This prompts increased gonadotropin-releasing hormone (GnRH) secretion from the hypothalamus, subsequently stimulating the pituitary gland to release more follicle-stimulating hormone (FSH) and luteinizing hormone (LH).
enclomisign
Enclomisign represents one of the more interesting developments in male reproductive endocrinology we’ve seen in recent years. It’s not your typical testosterone booster—this is a selective estrogen receptor modulator (SERM) specifically developed for men with secondary hypogonadism. What makes it unique is its ability to stimulate the pituitary to produce more luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn tells the testes to produce both testosterone and sperm. We’ve been using clomiphene for decades, but enclomisign is the purified enclomiphene isomer without the zuclomiphene component that causes some of the estrogenic side effects.